SIRPA and neoplasm: Blockage of the CD47/SIRPɑ axis is a successful strategy to stimulate macrophages against both hematologic and solid malignancies.4 In this review, we will discuss the strategies of macrophage engineering to achieve an anti‐tumor effect through blockage of the CD47/SIRPɑ axis.